Strides Pharma Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Dec-2022	Sep-2022	Jun-2022	Mar-2022
Gross Sales	986.37	864.85	897.10	940.07	866.02
Excise Duty	--	--	--	--	--
Net Sales	986.37	864.85	897.10	940.07	866.02
Other Operating Income	--	--	--	--	--
Other Income	27.12	67.76	56.55	13.55	86.06
Total Income	1013.49	932.61	953.65	953.62	952.08
Total Expenditure	878.75	891.96	843.81	1002.09	944.44
PBIDT	134.74	40.65	109.84	(48.46)	7.64
Interest	80.52	58.44	67.64	54.54	49.48
PBDT	54.22	(17.80)	42.20	(103)	(41.85)
Depreciation	60.93	60.22	61.70	60.40	60.68
Minority Interest Before NP	--	--	--	--	--
Tax	(15.67)	(2.08)	(18.12)	4.16	(154.52)
Deferred Tax	22.75	6.17	(20.29)	(32.23)	23.04
Reported Profit After Tax	(13.80)	(82.11)	18.90	(135.33)	28.96
Minority Interest After NP	(4.25)	(2.08)	(3.92)	0.56	(0.26)
Net Profit after Minority Interest	(9.54)	(80.03)	22.83	(135.89)	29.22
Extra-ordinary Items	15.41	38.28	33.09	(64.10)	(59.66)
Adjusted Profit After Extra-ordinary item	(24.95)	(118.31)	(10.26)	(71.79)	88.88
EPS (Unit Curr.)	(1.06)	(8.86)	2.54	(15.13)	3.25
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	90.30	90.29	90.29	89.79	89.79
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	13.66	4.70	12.24	(5.16)	0.88
PBDTM(%)	5.50	(2.06)	4.70	(10.96)	(4.83)
PATM(%)	(1.40)	(9.49)	2.11	(14.40)	3.34

QuickLinks for Strides Pharma Science Ltd.